Stepan Co (SCL) VP receives RSUs, SARs and performance share grants

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Stepan Co vice president Robin Joseph Weitkamp received new equity awards as part of compensation. On April 13, 2026, he was granted 2,859 restricted stock units, each representing a contingent right to one share of Stepan common stock, vesting ratably over three years.

He also received 4,030 stock appreciation rights on Stepan common stock at an exercise price of $52.46 per share, exercisable beginning April 13, 2027 and expiring April 13, 2036. In addition, he was granted 1,429 performance shares, each a contingent right to one share that vests only if Stepan certifies that performance goals are achieved for the period ending December 31, 2028. These awards are grants, not open‑market purchases or sales.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Weitkamp Robin Joseph

Role VP and GM Surfactants-INT

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	2,859	$0.00	--
Grant/Award	Stock Appreciation Right	4,030	$0.00	--
Grant/Award	Performance Shares	1,429	$0.00	--

Holdings After Transaction: Restricted Stock Units — 2,859 shares (Direct); Stock Appreciation Right — 4,030 shares (Direct); Performance Shares — 1,429 shares (Direct)

Footnotes (1)

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock. Vests ratably over three years beginning on the date shown. Each performance share represents a contingent right to receive one share of Stepan Company common stock. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.

Key Figures

Restricted stock units granted: 2,859 units Stock appreciation rights granted: 4,030 rights SAR exercise price: $52.46 per share +4 more

7 metrics

Restricted stock units granted 2,859 units RSUs granted on April 13, 2026; each equals one share, vesting over three years

Stock appreciation rights granted 4,030 rights SARs on common stock granted April 13, 2026

SAR exercise price $52.46 per share Exercise price for 4,030 stock appreciation rights

SAR first exercisable date April 13, 2027 Exercise start date for stock appreciation rights

SAR expiration date April 13, 2036 Expiration of stock appreciation rights grant

Performance shares granted 1,429 shares Performance share award contingent on meeting goals

Performance period end December 31, 2028 End date for performance goals governing performance shares

Key Terms

Restricted Stock Units, Stock Appreciation Right, Performance Shares, contingent right, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Stock Appreciation Right financial

"Stock Appreciation Right on Stepan Company common stock"

A stock appreciation right (SAR) is a form of employee pay that gives the holder the right to receive the increase in a company's share price over a set reference price, paid in cash or shares, without having to buy stock first. It matters to investors because SARs can create future cash outflows or dilute existing shareholders if settled in stock, and they align employee incentives with share-price performance like a bonus tied to a home's price rise.

Performance Shares financial

"Each performance share represents a contingent right to receive one share"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

contingent right financial

"represents a contingent right to receive one share of Stepan Company"

performance goals financial

"vest upon the certification of Stepan Company achieving certain performance goals"

Performance goals are specific, measurable targets a company sets for financial results, operational milestones, or individual roles—examples include revenue, profit, production levels, or completion of a project. They matter to investors because meeting or missing these targets influences management pay, future forecasts, deal-related payments and market confidence; think of them as a scoreboard that helps outsiders judge whether the business is performing as promised.

Form 4 Insider Transactions: What Each Field Means →

04/15/2026 - 04:27 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weitkamp Robin Joseph

(Last)

(First)

(Middle)

1101 SKOKIE BLVD, SUITE 500

(Street)

NORTHBROOK

ILLINOIS

60062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP and GM Surfactants-INT

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽¹⁾	04/13/2026		A		2,859		04/13/2027⁽²⁾	04/13/2029	Restricted Stock Units	2,859	$0	2,859	D
Stock Appreciation Right	$52.46	04/13/2026		A		4,030		04/13/2027⁽²⁾	04/13/2036	Common Stock	4,030	$0	4,030	D
Performance Shares	⁽³⁾	04/13/2026		A		1,429		⁽⁴⁾	⁽⁴⁾	Common Stock	1,429	$0	1,429	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

2. Vests ratably over three years beginning on the date shown.

3. Each performance share represents a contingent right to receive one share of Stepan Company common stock.

4. The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.

	/s/ James A. Hart, attorney-in-fact for Mr. Robin J. Weitkamp	04/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Stepan Co (SCL) disclose about Robin Joseph Weitkamp's new equity awards?

Stepan Co reported that VP Robin Joseph Weitkamp received 2,859 restricted stock units, 4,030 stock appreciation rights, and 1,429 performance shares. All awards are contingent rights to Stepan common stock and represent compensation, not open‑market stock purchases or sales.

How many restricted stock units did Robin Joseph Weitkamp receive from Stepan Co (SCL)?

Robin Joseph Weitkamp received 2,859 restricted stock units from Stepan Co. Each unit represents a contingent right to one share of Stepan common stock and will vest in equal installments over three years starting on the grant date shown.

What are the key terms of the stock appreciation rights granted by Stepan Co (SCL)?

Stepan Co granted 4,030 stock appreciation rights on its common stock with a $52.46 exercise price, first exercisable April 13, 2027. These rights expire April 13, 2036 and are derivative compensation rather than immediate share purchases or open‑market transactions.

What performance period applies to Robin Joseph Weitkamp's Stepan Co (SCL) performance shares?

The performance shares vest based on Stepan Co’s achievement of performance goals for the period ending December 31, 2028. Each of the 1,429 performance shares is a contingent right to one common share, vesting only after performance certification.

Are Robin Joseph Weitkamp's Stepan Co (SCL) Form 4 transactions open‑market trades?

No. The Form 4 transactions reflect equity compensation grants, including restricted stock units, stock appreciation rights, and performance shares. They are coded as awards, not open‑market buys or sells, and therefore do not represent discretionary trading in Stepan Co shares.

How do the Stepan Co (SCL) restricted stock units for Robin Joseph Weitkamp vest?

The restricted stock units vest ratably over three years beginning on the grant date. This means the 2,859 units convert into Stepan common shares in equal portions each year, assuming continued service and satisfaction of any award conditions.